AlphaStocks
5.3
Consider Buy

CONMED Corp (CNMD)

As of Sep 20, 2026, CONMED Corp (CNMD) scores 5.3/10 on AlphaStocks' five-model composite, #88 of 168 Health Care stocks. At $45, CNMD trades 15% above its model fair value of $40.

Health Care / Health Care Equipment

S&P SmallCap 600

$45.41

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#88out of 168 in Health Care

Is CONMED Corp a Good Investment in 2026?

CONMED Corp (CNMD) scores 5.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates CONMED Corp as Attractive (6/9). However, the Lynch model rates it Caution — PEG 1.5 · Fast Grower. CONMED Corp currently trades 15% above its estimated fair value of $40. CONMED Corp ranks #88 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E30.0ROE4.6Market Cap1BDiv Yield2.1

Estimated Fair Value

$39.6515% above

Trading above estimated fair value. Eps growth of -64% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Caution

Business quality & competitive moat

Graham

Neutral

14% above fair value

Lynch

Caution

PEG 1.5 · Fast Grower

Greenblatt

Attractive

Earnings yield 5.2% · ROC 22%

Frequently Asked Questions

Is CONMED Corp (CNMD) a good investment?
As of Sep 20, 2026, CONMED Corp (CNMD) scores 5.3/10 on AlphaStocks' five-model composite, #88 of 168 Health Care stocks. At $45, CNMD trades 15% above its model fair value of $40. That score is below average, suggesting caution.
What is CONMED Corp's Piotroski F-Score?
CONMED Corp's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CNMD overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $40, CNMD appears overvalued. The stock currently trades 15% above its estimated fair value. Trading above estimated fair value. Eps growth of -64% may not justify the premium.
How does CNMD compare to other Health Care stocks?
CONMED Corp ranks #88 out of 168 stocks in the Health Care sector, placing it in the top 52% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about CNMD?
AlphaStocks evaluates CNMD using five proven investment models. Piotroski: Attractive; Buffett: Caution; Graham: Neutral; Lynch: Caution; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 5.3/10.

Similar Stocks

INSPUFPTBDX

Compare CNMD with

CNMD vs INSPCNMD vs UFPTBDX vs CNMD

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer